Liver steatosis coexists with myocardial insulin resistance and coronary dysfunction in patients with type 2 diabetes.
about
Association of Nonalcoholic Fatty Liver Disease with Subclinical Cardiovascular Changes: A Systematic Review and Meta-AnalysisNonalcoholic fatty liver disease and vascular disease: state-of-the-art.Cardiovascular disorders in the context of non-alcoholic Fatty liver disease: a literature reviewAlterations in ventricular structure and function in obese adolescents with nonalcoholic fatty liver disease.A Mouse Model of Metabolic Syndrome: Insulin Resistance, Fatty Liver and Non-Alcoholic Fatty Pancreas Disease (NAFPD) in C57BL/6 Mice Fed a High Fat Diet.Nonalcoholic fatty liver disease and the heart in children and adolescents.Waist circumference adjusted for body mass index and intra-abdominal fat mass.Liver fat content in type 2 diabetes: relationship with hepatic perfusion and substrate metabolism.Pediatric nonalcoholic fatty liver disease, metabolic syndrome and cardiovascular riskThe severity of Fatty liver disease relating to metabolic abnormalities independently predicts coronary calcificationNonalcoholic fatty liver disease is associated with left ventricular diastolic dysfunction in patients with type 2 diabetes.Association of nonalcoholic fatty liver disease with subclinical myocardial remodeling and dysfunction: A population-based study.Subclinical inflammation in relation to insulin resistance in prediabetic subjects with nonalcoholic fatty liver disease.Severe diabetes and leptin resistance cause differential hepatic and renal transporter expression in mice.Myocardial insulin action and the contribution of insulin resistance to the pathogenesis of diabetic cardiomyopathy.Adaptation and maladaptation of the heart in obesity.Extrahepatic Manifestations of Nonalcoholic Fatty Liver DiseaseAnimal models of insulin resistance and heart failure.Nonalcoholic fatty liver disease and diabetes mellitus.Nonalcoholic Fatty liver: a possible new target for type 2 diabetes prevention and treatment.Effects of acute exercise and chronic exercise on the liver leptin-AMPK-ACC signaling pathway in rats with type 2 diabetes.Risk of cardiovascular, cardiac and arrhythmic complications in patients with non-alcoholic fatty liver diseaseNon alcoholic steatohepatitis is associated with subclinical impairment in left ventricular function measured by speckle tracking echocardiography.Lipids in the wrong place: visceral fat and nonalcoholic steatohepatitis.Nonalcoholic fatty liver disease and diabetes mellitus: pathogenesis and treatment.Non-alcoholic fatty liver disease: a new and important cardiovascular risk factor?Increased risk of cardiovascular disease and chronic kidney disease in NAFLD.Intracellular lipid accumulation and shift during diabetes progression.Nonalcoholic Steatohepatitis is Associated with Cardiac Remodeling and Dysfunction.Cardiovascular Disease and Myocardial Abnormalities in Nonalcoholic Fatty Liver Disease.Hexosamine biosynthesis pathway flux promotes endoplasmic reticulum stress, lipid accumulation, and inflammatory gene expression in hepatic cells.Hard clinical outcomes in patients with NAFLD.Frequency and risk factors associated with non-alcoholic fatty liver disease in patients with type 2 diabetes mellitus.Hepatic steatosis, carotid atherosclerosis and metabolic syndrome: the STEATO Study.Increased severity of liver fat content and liver fibrosis in non-alcoholic fatty liver disease correlate with epicardial fat volume in type 2 diabetes: A prospective study.NAFLD/NASH in patients with type 2 diabetes and related treatment options.Left ventricular dysfunction in obese children and adolescents with nonalcoholic fatty liver disease.Reversibility of myocardial metabolism and remodelling in morbidly obese patients 6 months after bariatric surgery.Low-dose attenuation correction in diagnosis of non-alcoholic fatty liver disease.A High-Fat and High-Cholesterol Diet Induces Cardiac Fibrosis, Vascular Endothelial, and Left Ventricular Diastolic Dysfunction in SHRSP5/Dmcr Rats.
P2860
Q26798155-09719C59-ADFF-4CB2-AA86-FF39A546136EQ27692035-15821318-4117-4B1F-BFDC-70333FDC91F5Q28081066-91A71375-8475-48E8-9A05-6CA136A84B28Q30437623-0A53EB72-8B97-46DD-9AEC-7C85BD1D2CB9Q33858409-C10A3D72-292E-4793-B141-37CE8DD83CA2Q33958722-907DEE28-F6CF-4FF6-B4B1-D474D1CED4A2Q34182363-1241C2CC-4DEC-4488-B7A6-CB5D92BF542CQ34237602-DE4F8510-46BF-4B08-B5BB-ADAF4DD3E550Q35171570-21E91EBF-668E-405F-80EF-244E99C2BE1FQ35664425-5F44883A-3A1A-4CBB-A6A8-CFAD83935C86Q35688259-33C2AFDC-176E-4335-9748-2442470B13FBQ35995660-19638336-D266-4055-A160-447B26188AF1Q36015048-D66E187A-A42E-4A06-B229-928550841C35Q36156379-FBF0CC7D-D2BC-4075-BB9E-7C035B333898Q36844816-EA9D2EA0-A2AC-4FDB-ACB4-C53EABE3449EQ36862876-8386D481-B687-4998-9118-41E0D469533DQ36921610-9CD5C7A1-79AA-425B-ACA4-041D5F8D9F71Q36944915-15EA493E-3E65-4F34-905A-696417C1D082Q37037458-C7BB06A2-A84D-486E-BF43-641D71BB921AQ37375539-54898D02-639C-4E2F-A374-7D2AB2AEAE3EQ37424332-C5904AB0-27CB-4DD6-BA25-40C58184EAD0Q37596189-DA598653-E14D-4B8A-AD11-D0B62F72F5BAQ37680608-6E3AC503-DF8F-414A-B9F5-4AB522F2927CQ37869703-BD618A46-10ED-4ACC-8EBA-8B352413A29CQ37873715-30B2EAA4-2FD0-4604-9D3D-F7C688D49AE7Q37992604-B68AD783-7140-441F-BA3B-BCE59B2BCF68Q38008136-D5135E59-AAD6-48FF-8817-9536D42CA918Q38232287-5F5449AC-712A-4ED0-9BD5-BF5A1D490A74Q38660839-9D1FDC81-FFB8-4FAD-BE0F-C2EEF2F98E18Q38711424-2FFD7F68-182C-4621-A95D-3D92754A8B68Q39768528-F6E37334-7305-44E0-9D2E-0FC3A36927F9Q40706265-89C649A2-DF73-4C10-AF59-D511E63BA722Q42972173-BFDDD5FA-A2D7-4186-BC27-8DD287C75687Q43267351-1FB048CB-0C6D-419A-85CE-6906CC784A04Q46220517-FC82E802-8A7B-4BD1-86F6-6A9B08A6AB78Q47592767-A1CFB7B3-7563-44CC-96AC-0A1382569A64Q48030343-F576BFA8-E2D4-402E-8846-ADE80878492BQ48175870-A20366A2-E706-48D3-AC9A-AB0607C911A7Q48607503-CAFA3247-13C0-47B4-9E23-4B24A6811114Q49834000-C08AD379-DA60-4D2A-A5E0-F24F8BA40F26
P2860
Liver steatosis coexists with myocardial insulin resistance and coronary dysfunction in patients with type 2 diabetes.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
Liver steatosis coexists with ...... patients with type 2 diabetes.
@en
Liver steatosis coexists with ...... patients with type 2 diabetes.
@nl
type
label
Liver steatosis coexists with ...... patients with type 2 diabetes.
@en
Liver steatosis coexists with ...... patients with type 2 diabetes.
@nl
prefLabel
Liver steatosis coexists with ...... patients with type 2 diabetes.
@en
Liver steatosis coexists with ...... patients with type 2 diabetes.
@nl
P2093
P2860
P50
P1476
Liver steatosis coexists with ...... patients with type 2 diabetes.
@en
P2093
Markku Komu
Marko Salmi
Pirjo Nuutila
Riikka Lautamäki
Riitta Parkkola
Sirpa Jalkanen
P2860
P304
P356
10.1152/AJPENDO.00604.2005
P577
2006-02-14T00:00:00Z